In patients with early-stage follicular lymphoma undergoing definitive RT, do you approach grade 3a disease any differently than grade 1-2 (radiation dose, fields/margins, systemic therapy)?   


Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at University Hospital Basel
I totally agree with Dr. @Beriwal. The German MIR...
Sign in or Register to read more